Add BrightSurf on Google Email

Science News Archive April 2009 - Page 14


Page 14 of 24

Shedding some light on Parkinson's treatment

Researchers have identified a group of cells as direct targets of deep brain stimulation (DBS) using optogenetics, which reduces disease symptoms by preferentially activating neurons linked to the subthalamic nucleus region. The technique allows precise stimulation and measurement of treatment effects simultaneously in animals with Par...

Penn scientists use RNA to reprogram 1 cell type into another

Researchers at the University of Pennsylvania School of Medicine have found a way to change one cell type into another by flooding it with specific messenger RNAs from another cell type. This approach, called Transcriptome induced phenotype remodeling (TIPeR), offers the possibility for a new type of cell-based therapy for neurodegener...

SourceUniversity of Pennsylvania School of Medicine·JournalProceedings of the National Academy of Sciences·DateApr 16, 2009

Treating sleep disorders in people with traumatic brain injury may not eliminate symptoms

A study published in the Journal of Clinical Sleep Medicine found that treating sleep disorders in adults with traumatic brain injury (TBI) may not lead to improvements in daytime sleepiness. Despite significant reductions in sleep apnea severity, participants showed no changes in mood, quality of life, or cognitive performance.

SourceAmerican Academy of Sleep Medicine·JournalJournal of Clinical Sleep Medicine·DateApr 15, 2009

Brain mechanisms for behavioral flexibility

The study suggests that neural pathways governing sensory and motor associations accomplish task switching through learning and communication of distinct populations of MT neurons into a downstream decision system. This finding is important for understanding both normal cognition and psychiatric disorders.

SourceCell Press·JournalNeuron·DateApr 15, 2009

Can EUS elastography help distinguish benign from malignant tissue?

A multicenter study found EUS elastography to be highly sensitive and specific in distinguishing benign from malignant tissue, with a sensitivity of 92.3% for pancreatic lesions and 91.8% for lymph nodes. The technique may help characterize pancreatic masses after negative EUS-FNA and increase the yield of EUS-FNA for lymph nodes.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateApr 15, 2009

Dannie Heineman prizes for 2009

The American Institute of Physics (AIP) awards the 2009 Dannie Heineman Prizes to Carlo Becchi, Alain Rouet, Raymond Stora, and Igor Tyutin for their discovery and exploitation of BRST symmetry in gauge theories. Lennox Cowie receives the astrophysics prize for his innovative observations of the distant universe.

DECIPHERing human disease

The DECIPHER database has revealed its developing role in revolutionizing both clinical practice and genetic research, providing a key to unlock the causes of illnesses. The data from around 100 centres has been shared openly worldwide, benefiting researchers, clinicians, and patients.

SourceWellcome Trust Sanger Institute·JournalAmerican Journal of Human Genetics·DateApr 15, 2009

Chemists synthesize herbal alkaloid

A team of chemists at Vanderbilt University has successfully synthesized Serratezomine A, a potentially anti-cancer herbal alkaloid, in six years through an efficient process. This achievement could lead to the development of new treatments for cancer and other diseases.

SourceVanderbilt University·JournalJournal of the American Chemical Society·DateApr 15, 2009

New minimally invasive surgery option for patients with stomach cancer

A new study led by Memorial Sloan-Kettering Cancer Center compares traditional 'open' surgery to laparoscopic gastrectomy, a minimally invasive procedure. The findings demonstrate that laparoscopic surgeries yielded shorter hospital stays and fewer complications after surgery while maintaining similar rates of recurrence-free survival.

SourceMemorial Sloan Kettering Cancer Center·JournalAnnals of Surgical Oncology·DateApr 15, 2009

Long-lasting nerve block could change pain management

Researchers at Boston Children's Hospital have created a slow-release anesthetic drug-delivery system, showing promise for prolonged pain relief without toxicity in rats. The formulation, using liposomes to package saxitoxin, produced nerve blocks lasting two days or seven days when combined with dexamethasone.

SourceBoston Children's Hospital·JournalProceedings of the National Academy of Sciences·DateApr 15, 2009